Medical Shortage and COVID


Another Plea for Early COVID Treatment

Subscribe button

As I write this in late January, the local hospital here in South Carolina has been overrun with sick, COVID-positive patients for weeks. The stress of dealing with the onslaught is compounded by a staff shortage, due to ill health and burnout from dealing with the extra PPE measures, high number of patients, and anxiety. Our hospital is not an anomaly. Staffing shortages have hit hospitals across the nation.1 Stat News says, “Their only hope is for demand to decrease by people reducing Covid-19 transmission through quarantining and wearing masks….”1 The vaccination program will not necessarily stop the spread. People who receive the experimental mRNA vaccines, made by Pfizer or Moderna, “may still be able to transmit the virus,” according to the American Academy of Family Physicians.2

The one option that is rarely talked about is early, out-patient treatment that keeps people from needing hospitalization.

At the December 8, 2020, US Senate Homeland Security and Government Affairs Committee hearing, pulmonologist Pierre Kory presented studies and other documentation that the anti-parasitic drug ivermectin “basically obliterates transmission of this virus. If you take it, you will not get sick.”3 In addition, mortality rates decreased in hospitalized COVID patients who received the drug. Dr. Kory is part of Frontline COVID-19 Critical Care Alliance (https://covid19criticalcare.com/), a group of highly published physicians, led by Professor Paul E. Marik. This group published the MATH+ integrative protocol in March 2020.

Kory told the Senate committee, “We need to offload the hospitals, we are tired. I can’t keep doing this. If you look at my manuscript, and if I have to go back to work next week, any further deaths are going to be needless deaths, and I cannot be traumatized by that. I cannot keep caring for patients when I know that they could have been saved with earlier treatment and that drug that will treat them and prevent the hospitalization is ivermectin.”

On January 14, 2020, the National Institutes of Health removed its barrier to using ivermectin for prevention and treatment of COVID-19. Instead of being “against” use, NIH upgraded its status to “neither for nor against.” In a response, Kory’s group asked that NIH provide doctors more guidance in its use.4

Although ivermectin has a good safety profile, adverse side effects are possible, according to Drugs.com. Humans should not take ivermectin intended for animal use.5

How long will it take for this information to reach frontline doctors and practitioners?

Jule Klotter

  1. Goldhill O. ‘People are going to die’: Hospitlas in half the states are facing a massive staffing shortage as COVID-19 surges.  November 19, 2020. www.statnews.com
  2. COVID-19 Vaccine FAQ. https://www.aafp.org/dam/AAFP/documents/patient_care/public_health/COVID19-Vaccine-FAQs.pdf
  3. Medical Response to COVID-19. December 8, 2020. https://www.c-span.org/video/?507035-1/medical-response-covid-19
  4. FLCCC Alliance Response to the NIH Guideline Committee Recommendation on Ivermectin use in COVID-19 dated January 14th, 2021. https://covid19criticalcare.com/wp-content/uploads/2021/01/FLCCC-Alliance-Response-to-the-NIH-Guideline-Committee-Recommendation-on-Ivermectin-use-in-COVID19-2021-01-18.pdf
  5. Can ivermectin be used to treat COVID-19 (coronavirus)?  Updated December 29, 2020. https://www.drugs.com/medical-answers/ivermectin-treat-covid-19-coronavirus-3535912/